Individualized transcriptomic changes in malignant and benign prostate identify markers of disease recurrence
RNA-seq (gene expression) · human · 82 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 82 samples: 82 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE316750_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1404129 and SRA study SRP663580. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 82 sample titles: 82 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9459412 Cancer_0259_1
- GSM9459413 Benign_0259_2
- GSM9459414 Benign_0263_1
- GSM9459415 Cancer_0263_2
- GSM9459416 Benign_0266_1
- GSM9459417 Cancer_0266_2
- GSM9459418 Cancer_0272_1
- GSM9459419 Benign_0272_2
- GSM9459420 Cancer_0274_1
- GSM9459421 Benign_0274_2
- GSM9459422 Benign_0275_1
- GSM9459423 Cancer_0275_2
- GSM9459424 Benign_0294_1
- GSM9459425 Cancer_0294_2
- GSM9459426 Cancer_104_1
- GSM9459427 Benign_104_2
- GSM9459428 Cancer_114_1
- GSM9459429 Benign_114_2
- GSM9459430 Benign_116_1
- GSM9459431 Cancer_116_2
- GSM9459432 Benign_125_1
- GSM9459433 Cancer_125_2
- GSM9459434 Cancer_126_1
- GSM9459435 Benign_126_2
- GSM9459436 Cancer_136_1
- GSM9459437 Benign_136_2
- GSM9459438 Cancer_137_1
- GSM9459439 Benign_137_2
- GSM9459440 Benign_138_1
- GSM9459441 Cancer_138_2
- GSM9459442 Benign_151_3
- GSM9459443 Cancer_151_4
- GSM9459444 Benign_152_3
- GSM9459445 Cancer_152_4
- GSM9459446 Cancer_154_1
- GSM9459447 Benign_154_2
- GSM9459448 Benign_158_1
- GSM9459449 Cancer_158_2
- GSM9459450 Benign_167_1
- GSM9459451 Cancer_167_2
+ 42 more — browse all 82 samples with per-sample file links →
- GSE311200 Comprehensive analysis of the correlation between circulating biomarkers and tumor-immune microenvironment in advanced or recurrence non-small cell lung cancer in various treatment options, i.e., immunotherapy, EGFR TKI, and chemotherapy 41 samples shares recurrence, markers
- GSE314805 Prostate Tumor Immune Microenvironment Changes Following Immunotherapy Shared by Patients who Developed Anti-Tumor Response or Immune-Related Adverse Events 24 samples shares prostate, changes
- GSE277524 Single-cell dissection of multifocal bladder cancer reveals malignant and immune cells variation between primary and recurrence tumor lesions 10 samples shares recurrence, malignant
- GSE264573 Single Cell Analysis of Treatment–Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies 4 samples shares prostate, changes
- GSE282574 Genome-scale DNA methylome and transcriptome profiles of early prostate cancer recurrence after prostatectomy 29 samples shares recurrence, prostate
- GSE269205 Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia 12 samples shares prostate, benign
- GSE319666 Archetype analysis of lung adenocarcinoma premalignancy links heterogeneity in premalignant lesions to diverging features of invasive disease 177 samples shares malignant
- GSE328302 Identification of two genes associated with recurrence in Paget’s disease and construction of a predictive model 39 samples shares recurrence
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.